Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Carboplatin/Nab-Paclitaxel with Trastuzumab or Bevacizumab in Breast Cancer
NCT00618657Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Feb 2008
- Primary completion
- Jul 2021
- Modality
- Antibody Conjugates, Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin, trastuzumab, bevacizumab in breast cancer, sponsored by University of California, Irvine. Started Feb 2008; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00618657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00618657.